ArticleThe journal of pathology. Clinical research2022

PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer.

Sofie Olsson Hau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.